Provided by Tiger Trade Technology Pte. Ltd.

Quest Diagnostics

231.09
-1.9800-0.85%
Post-market: 231.090.00000.00%17:35 EDT
Volume:1.03M
Turnover:237.71M
Market Cap:25.51B
PE:24.54
High:233.33
Open:232.74
Low:230.47
Close:233.07
52wk High:248.84
52wk Low:171.18
Shares:110.37M
Float Shares:110.00M
Volume Ratio:0.96
T/O Rate:0.93%
Dividend:3.32
Dividend Rate:1.44%
EPS(TTM):9.42
EPS(LYR):8.75
ROE:14.60%
ROA:6.40%
PB:3.39
PE(LYR):26.41

Loading ...

Apple's Betting Improved Heart and Health Insights Will Boost Watch Sales

Dow Jones
·
6 hours ago

Quest Study Shows Haystack MRD Test Hits 100% Specificity in Dynamic Colorectal Cancer Specimen Cohort

Reuters
·
Yesterday

Haystack Mrd® Demonstrates Robust Clinical Performance in Specimen Cohort from the Landmark Dynamic Colorectal Cancer Trials

THOMSON REUTERS
·
Yesterday

Quest Diagnostics (DGX) Could Be 6% Undervalued After Florida ECG Screening Push

Simply Wall St.
·
Yesterday

Quest Diagnostics Inc. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Sep 30

Quest Diagnostics Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 25

DaVita Inc. Stock Falls 4.6%, Underperforms Peers

Dow Jones
·
Sep 25

Analysts Offer Insights on Healthcare Companies: Quest Diagnostics (DGX), AnaptysBio (ANAB) and Vertex Pharmaceuticals (VRTX)

TIPRANKS
·
Sep 23

Quest Diagnostics Inc. Stock Slides 4.1%, Underperforms Peers

Dow Jones
·
Sep 23

Quest Diagnostics to Report Q3 Results, Host Conference Call Before Market Open

Reuters
·
Sep 23

Movement Alert|Quest Diagnostics Falls 5.15% in Regular Trading, Medicare Signals $1 Billion in Lab Service Payment Cuts

Market Focus
·
Sep 23

Sandisk, GameStop, Viking Therapeutics, Vicor, on Holding, and More Stocks That Explain Today's Market

Dow Jones
·
Sep 22

Quest Diagnostics on Pace for Largest Percent Decrease Since July 2023

Dow Jones
·
Sep 22

Quest Diagnostics, Labcorp Shares Fall as Medicare Signals Cuts in Payment Rates for Lab Services

MT Newswires Live
·
Sep 22

Movement Alert|Quest Diagnostics Falls 6.08% in Pre-Market Trading, Trading at $230.0

Market Focus
·
Sep 22

Quest Diagnostics Study Finds 29.5% of Lyme-Seropositive Patients Show Antibodies to Other Tick-Borne Pathogens

Reuters
·
Sep 21

Truist Raises Price Target on Quest Diagnostics to $260 From $250, Keeps Hold Rating

MT Newswires Live
·
Sep 21

S&P 500 Top and Bottom Performing Stocks at About 12:00 P.m. EDT

Reuters
·
Sep 16

Quest Diagnostics Inc. Stock Underperforms Monday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Sep 15

Quanterix Names Yuri Fesko as Chief Medical Officer

Reuters
·
Sep 14